Thomas Engström (Former)
21 – 36 of 36
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2019
-
Mark
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions : meta-analysis of individual patient data
(
- Contribution to journal › Article
-
Mark
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease : A DANAMI-3–PRIMULTI Cardiac Magnetic Resonance Substudy
(
- Contribution to journal › Article
-
Mark
Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI
(
- Contribution to journal › Article
-
Mark
Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI
(
- Contribution to journal › Article
- 2018
-
Mark
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI : A DANAMI-3 substudy
(
- Contribution to journal › Article
-
Mark
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
A comprehensive evaluation of the genetic architecture of sudden cardiac arrest
(
- Contribution to journal › Article
-
Mark
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
(
- Contribution to journal › Article
-
Mark
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients : A phase 2 randomised clinical trial
(
- Contribution to journal › Article
-
Mark
Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients
(
- Contribution to journal › Article
-
Mark
Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction
(
- Contribution to journal › Article
- 2017
-
Mark
Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : A Swedish nationwide observational study
(
- Contribution to journal › Article
-
Mark
The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction
(
- Contribution to journal › Article
- 2015
-
Mark
Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI : an observational comparative study
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »